Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
11/2000
11/23/2000CA2373892A1 Glucagon antagonists/inverse agonists
11/21/2000US6150530 Amidation of amine with acid
11/21/2000US6150417 Administering to warm blooded animals compounds such as n-tert-butyl-5-((2-(2-methoxyphenoxy)ethyl)amino)pentanamide for inducing antiemetic activity; treating anxiety, depression, and sleep disorders
11/21/2000US6150344 Useful for treatment of diseases such as malaria and alzheimer's disease; compounds are attached to a solid support
11/16/2000WO2000068185A1 A structure-based approach to design inhibitors of protein-processivity factor interactions
11/16/2000WO2000068178A1 Novel compounds
11/16/2000WO2000006525A3 Synthesis of combinatorial libraries of compounds reminiscent of natural products
11/16/2000WO2000000158A3 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function
11/16/2000CA2373182A1 A structure-based approach to design inhibitors of protein-processivity factor interactions
11/16/2000CA2336673A1 Novel compounds
11/15/2000EP1051397A1 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/15/2000EP1051391A1 N-alkylation of 5-amino-2,4,6-triiodo-isophthalamides
11/15/2000EP1051143A2 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives
11/15/2000CN1273574A Process for crystallisation of sterically hindered compound
11/14/2000US6147240 Isocyanoalkyl carbonic acid derivatives, their conversion into secondary amidoalkyl carbonic acid derivatives by isocyanide-multicomponent reactions, as well as these secondary amidoalkyl carbonic acid derivatives
11/09/2000WO2000066613A1 Bone targeting agents for osteoporosis
11/09/2000WO2000066544A1 Contrast media
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000030688A3 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/08/2000EP1049665A1 Vla-4 antagonists
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/07/2000US6143161 Process for the preparation of 4-(des-dimethylamino)-tetracyclines
11/07/2000CA2156455C Glycinamide derivatives, processes for their preparation and medicines containing them
11/07/2000CA1341136C Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
11/02/2000WO2000064863A1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
11/02/2000WO2000064858A1 Bipolar lipids and their use for the delivery of bioactive substances
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
11/02/2000EP1047431A1 Pharmaceutically active compounds and methods of use thereof
11/01/2000CN1057997C Process for preparing p-nitroaromatic amides and products thereof
10/2000
10/31/2000US6140369 Particularly, dopamine depletion-associated neurodegenerative condition of the central nervous system; parkinson's disease; alzheimer's disease; mitochondrial dysfunction; abnormal dopamine depletion in selected regions of the brain
10/31/2000US6140362 Method for inhibiting the growth of mammalian cells
10/26/2000WO2000063186A1 Process and intermediates for preparing benzodiazepines
10/26/2000WO2000063170A1 Cyclobutene-3,4-dione derivatives as inhibitors of phosphodiesterase 5
10/26/2000WO2000063161A1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes
10/26/2000WO2000063160A1 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000CA2370742A1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes
10/25/2000EP1045830A1 Alpha-aminoamide derivatives useful as analgesic agents
10/25/2000EP0897382B1 Alkoxy acetic acid derivatives
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000CN1271342A Synthesis of clasto-lactacystin-beta-lactone and analogs thereof
10/25/2000CN1271279A Amide derivatives for the treatment of diseases mediated by cytokines
10/25/2000CN1270956A 3-{N-[2-(N',N'-dimethyl amino oxyethyl group) ethyl] N-methylamino} propionamide used for producing polyurethane
10/25/2000CN1057755C Fluoroalkenyl compounds and preparing method
10/24/2000US6137006 Preparation of tri-iodo benzene compounds
10/19/2000WO2000061569A1 Adamantane derivatives
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061537A2 Pharmaceutical compounds
10/19/2000CA2369619A1 Caspase inhibitors and the use thereof
10/19/2000CA2368829A1 Adamantane derivatives
10/18/2000EP1044186A1 Substituted 2-benzylamino-2-phenyl-acetamide compounds
10/18/2000CN1270585A Substituted 1,2,3,4-tetrahydronaphthalene derivatives
10/17/2000US6133457 Process for preparing pharmaceutical compounds
10/17/2000US6133308 Synthesis of clasto-lactacystin beta-lactone and analogs thereof
10/17/2000US6133252 Fungicides for the control of take-all disease of plants
10/17/2000US6133002 Acetalization of dialdehyde with alcohol, diol, or orthoformic ester; amination, cyanation, oxidation; enantioselective hydrolysis
10/12/2000WO2000059875A2 Novel inhibitors of formation of advanced glycation endproducts (age's)
10/12/2000WO2000059868A1 Substituted aniline compounds
10/12/2000WO2000059867A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties
10/12/2000CA2368703A1 Substituted aniline compounds
10/11/2000EP1043332A1 Dipeptides comprising cyclopentan-beta-amino acids
10/11/2000EP1043308A1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
10/11/2000EP1042279A1 Substituted beta-alanines
10/11/2000EP1042276A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/11/2000EP1042275A1 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
10/11/2000EP1041995A1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
10/11/2000EP0773930B1 Aromatic amino ethers as pain relieving agents
10/11/2000EP0754672B1 Gamma-substituted phenylacetic acid derivative, process for producing the same, and agricultural bactericide containing the same
10/11/2000CN1269781A Method of purifying and recovering sweetener
10/11/2000CN1269136A Fluoric alkenyl compound and use as insect repellent agent
10/05/2000WO2000058288A1 Pyridine-2,3-dicarboxylic acid diamides
10/05/2000WO2000058271A1 Nitrogen mustard compounds and prodrugs therefor
10/05/2000WO2000058270A2 Hsv primase inhibitors
10/05/2000CA2368451A1 Pyridine-2,3-dicarboxylic acid diamides
10/05/2000CA2364622A1 Nitrogen mustard compounds and prodrugs therefor
10/04/2000EP1041064A2 N-substituted alpha aminoacid amides as calcium channel modulators
10/04/2000EP1040096A1 Neuroprotective agents
10/04/2000EP1039902A2 Inhibitors of gap junction communication
10/04/2000EP1039895A1 Use of 3-benzoyl-phenylacetic acids, esters, or amides for treatment of glc1a glaucoma
10/04/2000CN1268938A Aminocycloalkane compounds
10/03/2000US6127427 Active hydroxamic acids involved in tissue degradtion and also are inhibitors of the release of tumour necrosis factor from cells; rheumatoid arthritis, osteoarthritis, osteopenias such as osteoporosis, periodontitis, vision defects
10/03/2000US6127391 Compounds with growth hormone releasing properties
10/03/2000US6127354 For treatment of growth disorders or to stimulate production of wool or milk
10/03/2000US6127191 Solid support having plurality of pendant scaffold moieties covalently attached; for synthesis of bioactive molecules
10/03/2000CA2000342C Novel peptidase inhibitors
09/2000
09/30/2000CA2302144A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties
09/30/2000CA2267657A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties
09/28/2000WO2000056743A1 Pharmaceutical compositions comprising metal complexes
09/28/2000CA2367282A1 Pharmaceutical compositions comprising metal complexes
09/27/2000EP1038895A2 3- (N-(2-(N',N'-Dimethylamino Ethoxy)Ethyl) -N-Methylamino) Propionamide for the production of polyurethanes
09/27/2000EP1038864A1 Novel metalloproteinase inhibitors
09/27/2000EP1038522A2 Anticonvulsant enantiomeric amino acid derivatives
09/27/2000EP1037904A2 Branched building units for synthesizing cyclic peptides
09/27/2000CN1268129A Method for the preparation of citalopram
09/26/2000US6124471 Phenyldiboronic acid reagents and complexes
09/26/2000US6124270 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
09/26/2000US6124251 Toilet bowl cleaning tablet
09/26/2000US6123928 Combining two ultraviolet a and b absorbing acrylic polymers comprising an unsubstitued acrylic acid or substituted acrylic acid with a side chain having oxygen or nitrogen atom covalently attached to polyacrylic acid with a carrier
09/21/2000WO2000055124A2 Novel compounds and compositions as protease inhibitors
1 ... 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 ... 162